Skip to main content
Top
Published in: Ophthalmology and Therapy 1/2016

Open Access 01-06-2016 | Original Research

Pharmacological Treatment of Presbyopia by Novel Binocularly Instilled Eye Drops: A Pilot Study

Authors: Antonio Renna, L. Felipe Vejarano, Ernesto De la Cruz, Jorge L. Alió

Published in: Ophthalmology and Therapy | Issue 1/2016

Login to get access

Abstract

Purpose

The feasibility, in terms of safety and potential efficacy, of a new drug combination for binocular use as a noninvasive pharmacological solution for treating presbyopia was examined.

Methods

Fourteen emmetropic presbyopic subjects (28 eyes) were given one drop of the preparation under study in each eye. For each patient, the uncorrected distance visual acuity, uncorrected near visual acuity, near and far refraction, best corrected visual acuity, best corrected far-near visual acuity, photopic and scotopic pupil size, Schirmer’s test, endothelial cell count, intraocular pressure, keratometry, pachymetry, and anterior chamber depth were all performed or assessed prior to the administration of the eye drops and then 0.5, 1, 2, 3, 4, and 5 h, 1 week, and 1 month post-administration prospectively in each eye and binocularly.

Results

The results showed that near uncorrected visual acuity improved by about 2–3 lines from baseline in each eye and binocularly. There was no degradation in uncorrected far vision in each eye and binocularly in any patient. Refractive measurements performed in this study showed there was a maximum myopic shift of just 0.5 D that progressively reduced and disappeared at 4 h.

Conclusion

The new topical drug treatment analyzed herein significantly improved near vision without affecting far vision. This binocular pharmacologic treatment of presbyopia has the potential to ameliorate the reading vision of presbyopes and possesses the advantages of a nonmonovision therapy. A randomized, controlled, double-masked clinical trial with a twice-a-day treatment schedule is ongoing at our institution.

Funding

This study was supported in part by the Spanish Ministry of Health, Instituto Carlos III, Red Temática de Investigación Oftalmológica (OFTALRED), and Fundación Oftalmológica Vejarano (Popayán, Colombia).
Literature
1.
go back to reference McDonnell PJ, Lee P, Spritzer K, Lindblad AS, Hays RD. Associations of presbyopia with vision-targeted health-related quality of life. Arch Ophthalmol. 2003;121(11):1577–81.CrossRefPubMed McDonnell PJ, Lee P, Spritzer K, Lindblad AS, Hays RD. Associations of presbyopia with vision-targeted health-related quality of life. Arch Ophthalmol. 2003;121(11):1577–81.CrossRefPubMed
3.
go back to reference Charman WN. Developments in the correction of presbyopia. II: Surgical approaches. Ophthal Physiol Opt. 2014;34(4):397–426. Charman WN. Developments in the correction of presbyopia. II: Surgical approaches. Ophthal Physiol Opt. 2014;34(4):397–426.
4.
go back to reference Abdelkader A. Improved presbyopic vision with miotics. Eye Contact Lens Sci Clin Pract. 2015;41(5):323–7. Abdelkader A. Improved presbyopic vision with miotics. Eye Contact Lens Sci Clin Pract. 2015;41(5):323–7.
5.
go back to reference Glasser A. Accommodation: mechanism and measurement. Ophthalmol Clin N Am. 2006;19:1–12. Glasser A. Accommodation: mechanism and measurement. Ophthalmol Clin N Am. 2006;19:1–12.
6.
go back to reference Benozzi J, Benozzi G, Orman B. Presbyopia: a new potential pharmacological treatment. Med Hypothesis Discov Innov Ophthalmol. 2012;1(1):3–5.PubMedPubMedCentral Benozzi J, Benozzi G, Orman B. Presbyopia: a new potential pharmacological treatment. Med Hypothesis Discov Innov Ophthalmol. 2012;1(1):3–5.PubMedPubMedCentral
7.
go back to reference Crawford KS, Garner WH, Burns W. Dioptin™: a novel pharmaceutical formulation for restoration of accommodation in presbyopes. Invest Ophthalmol Vis Sci. 2014;55(13):3765. Crawford KS, Garner WH, Burns W. Dioptin™: a novel pharmaceutical formulation for restoration of accommodation in presbyopes. Invest Ophthalmol Vis Sci. 2014;55(13):3765.
8.
go back to reference Fraunfelder FT, Fraunfelder FW, Chambers WA. Drug-induced ocular side effects. 7th ed. Philadelphia: Elsevier Saunders; 2015. p. 320–323. Fraunfelder FT, Fraunfelder FW, Chambers WA. Drug-induced ocular side effects. 7th ed. Philadelphia: Elsevier Saunders; 2015. p. 320–323.
9.
go back to reference Vejarano LF. Ophthalmic formulation and method for ameliorating presbyopia. US patent number 20140024642 A1. 2014. Vejarano LF. Ophthalmic formulation and method for ameliorating presbyopia. US patent number 20140024642 A1. 2014.
10.
go back to reference Benozzi G, Leiro J, Facal S, Perez C, Benozzi J, Orman B. Developmental changes in accommodation evidenced by an ultrabiomicroscopy procedure in patients of Different Ages. Med Hypothesis Discov Innov Ophthalmol. 2013;2(1):8–13. Benozzi G, Leiro J, Facal S, Perez C, Benozzi J, Orman B. Developmental changes in accommodation evidenced by an ultrabiomicroscopy procedure in patients of Different Ages. Med Hypothesis Discov Innov Ophthalmol. 2013;2(1):8–13.
11.
go back to reference Hickenbotham A, Tiruveedhula P, Roorda A. Comparison of spherical aberration and small-pupil profiles in improving depth of focus for presbyopic corrections. J Cataract Refract Surg. 2012;38(12):2071–9.CrossRefPubMedPubMedCentral Hickenbotham A, Tiruveedhula P, Roorda A. Comparison of spherical aberration and small-pupil profiles in improving depth of focus for presbyopic corrections. J Cataract Refract Surg. 2012;38(12):2071–9.CrossRefPubMedPubMedCentral
12.
go back to reference Van De Sompel D, Kunkel GJ, Hersh PS, Smits AJ. Model of accommodation: contributions of lens geometry and mechanical properties to the development of presbyopia. J Cataract Refract Surg. 2010;36(11):1960–71.CrossRefPubMed Van De Sompel D, Kunkel GJ, Hersh PS, Smits AJ. Model of accommodation: contributions of lens geometry and mechanical properties to the development of presbyopia. J Cataract Refract Surg. 2010;36(11):1960–71.CrossRefPubMed
13.
go back to reference Richdale K, Sinnott LT, Bullimore MA, et al. Quantification of age-related and per diopter accommodative changes of the lens and ciliary muscle in the emmetropic human eye. Investig Ophthalmol Vis Sci. 2013;54(2):1095–105.CrossRef Richdale K, Sinnott LT, Bullimore MA, et al. Quantification of age-related and per diopter accommodative changes of the lens and ciliary muscle in the emmetropic human eye. Investig Ophthalmol Vis Sci. 2013;54(2):1095–105.CrossRef
14.
go back to reference Schwarz C, Manzanera S, Prieto PM, et al. Comparison of binocular through-focus visual acuity with monovision and a small aperture inlay. Biomed Opt Express. 2014;5:3355–66.CrossRefPubMedPubMedCentral Schwarz C, Manzanera S, Prieto PM, et al. Comparison of binocular through-focus visual acuity with monovision and a small aperture inlay. Biomed Opt Express. 2014;5:3355–66.CrossRefPubMedPubMedCentral
15.
go back to reference Mauduit P, Jammes H, Rossignol B. M3 muscarinic acetylcholine receptor coupling to PLC in rat exorbital lacrimal acinar cells. Am J Physiol. 1993;264:1550–60. Mauduit P, Jammes H, Rossignol B. M3 muscarinic acetylcholine receptor coupling to PLC in rat exorbital lacrimal acinar cells. Am J Physiol. 1993;264:1550–60.
16.
go back to reference Yu Y, Kawarai M, Koss MC. Histamine H3 receptor-mediated inhibition of sympathetically evoked mydriasis in rats. Eur J Pharmacol. 2001;419(1):55–9.CrossRefPubMed Yu Y, Kawarai M, Koss MC. Histamine H3 receptor-mediated inhibition of sympathetically evoked mydriasis in rats. Eur J Pharmacol. 2001;419(1):55–9.CrossRefPubMed
17.
go back to reference Sarkar S, Hasnat AM, Bharadwaj SR. Revisiting the impact of phenylephrine hydrochloride on static and dynamic accommodation. Indian J Ophthalmol. 2012;60(6):503–9.CrossRefPubMedPubMedCentral Sarkar S, Hasnat AM, Bharadwaj SR. Revisiting the impact of phenylephrine hydrochloride on static and dynamic accommodation. Indian J Ophthalmol. 2012;60(6):503–9.CrossRefPubMedPubMedCentral
18.
go back to reference Greiner JV, Udell IJ. A comparison of the clinical efficacy of pheniramine maleate/naphazoline hydrochloride ophthalmic solution and olopatadine hydrochloride ophthalmic solution in the conjunctival allergen challenge model. Clin Ther. 2005;27(5):568–77.CrossRefPubMed Greiner JV, Udell IJ. A comparison of the clinical efficacy of pheniramine maleate/naphazoline hydrochloride ophthalmic solution and olopatadine hydrochloride ophthalmic solution in the conjunctival allergen challenge model. Clin Ther. 2005;27(5):568–77.CrossRefPubMed
19.
go back to reference Morgan JT, Raghunathan VK, Chang YR, Murphy CJ, Russel P. The intrinsic stiffness of human trabecular meshwork cells increases with senescence. Oncotarget. 2015;6(17):15362–74.CrossRefPubMedPubMedCentral Morgan JT, Raghunathan VK, Chang YR, Murphy CJ, Russel P. The intrinsic stiffness of human trabecular meshwork cells increases with senescence. Oncotarget. 2015;6(17):15362–74.CrossRefPubMedPubMedCentral
20.
go back to reference Vejarano LF. Topical drops show promise as treatment for presbyopia. Ophthalmology Times. 2016 Feb 1. Vejarano LF. Topical drops show promise as treatment for presbyopia. Ophthalmology Times. 2016 Feb 1.
21.
go back to reference Cole J. A closer look at presbyopia. Rev Optom. 2016;153:54. Cole J. A closer look at presbyopia. Rev Optom. 2016;153:54.
Metadata
Title
Pharmacological Treatment of Presbyopia by Novel Binocularly Instilled Eye Drops: A Pilot Study
Authors
Antonio Renna
L. Felipe Vejarano
Ernesto De la Cruz
Jorge L. Alió
Publication date
01-06-2016
Publisher
Springer Healthcare
Published in
Ophthalmology and Therapy / Issue 1/2016
Print ISSN: 2193-8245
Electronic ISSN: 2193-6528
DOI
https://doi.org/10.1007/s40123-016-0050-x

Other articles of this Issue 1/2016

Ophthalmology and Therapy 1/2016 Go to the issue